REPAIR Impact Fund
Introduction
Novo Holdings is establishing the REPAIR Impact Fund to replenish the anti-infective pipeline and to combat antimicrobial resistance. The REPAIR (Replenishing and Enabling the Pipeline for Anti-Infective Resistance) Impact Fund will invest in companies involved in discovering and early-stage development of therapies targeting resistant microorganisms.
Watch our video about the REPAIR Impact Fund’s first year of operation